Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $4,150 | 6 | 55.3% |
| Food and Beverage | $2,375 | 111 | 31.6% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $800.00 | 2 | 10.7% |
| Entertainment | $180.77 | 4 | 2.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| IBSA Pharma Inc. | $5,360 | 31 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $715.71 | 31 | $0 (2024) |
| Romark Laboratories, LC | $678.12 | 34 | $0 (2020) |
| QOL Medical, LLC | $469.75 | 14 | $0 (2024) |
| AbbVie Inc. | $66.89 | 3 | $0 (2021) |
| Corcept Therapeutics | $59.10 | 2 | $0 (2024) |
| Janssen Biotech, Inc. | $41.89 | 2 | $0 (2019) |
| Regeneron Healthcare Solutions, Inc. | $25.48 | 1 | $0 (2023) |
| Alfasigma USA, Inc. | $24.50 | 1 | $0 (2022) |
| Esperion Therapeutics, Inc. | $18.55 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,502 | 15 | IBSA Pharma Inc. ($2,263) |
| 2023 | $955.28 | 17 | IBSA Pharma Inc. ($659.37) |
| 2022 | $2,661 | 22 | IBSA Pharma Inc. ($2,306) |
| 2021 | $156.69 | 9 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($78.28) |
| 2020 | $413.56 | 22 | Romark Laboratories, LC ($225.64) |
| 2019 | $300.15 | 12 | Romark Laboratories, LC ($135.75) |
| 2018 | $517.78 | 26 | Romark Laboratories, LC ($316.73) |
All Payment Transactions
123 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $42.71 | General |
| Category: THERAPY FOR CSID | ||||||
| 11/06/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), XIFAXAN | Food and Beverage | In-kind items and services | $15.82 | General |
| Category: Gastroenterology | ||||||
| 10/14/2024 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $40.23 | General |
| Category: THERAPY FOR CSID | ||||||
| 07/16/2024 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $38.26 | General |
| Category: THERAPY FOR CSID | ||||||
| 05/07/2024 | IBSA Pharma Inc. | Tirosint (Drug), Licart | Food and Beverage | Cash or cash equivalent | $4.58 | General |
| Category: Endocrinology | ||||||
| 04/25/2024 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $37.25 | General |
| Category: THERAPY FOR CSID | ||||||
| 04/10/2024 | IBSA Pharma Inc. | Tirosint (Drug) | Consulting Fee | Cash or cash equivalent | $1,200.00 | General |
| Category: Endocrinology | ||||||
| 04/10/2024 | IBSA Pharma Inc. | Tirosint (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $300.00 | General |
| Category: Endocrinology | ||||||
| 04/10/2024 | IBSA Pharma Inc. | Tirosint (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Endocrinology | ||||||
| 02/28/2024 | IBSA Pharma Inc. | Tirosint (Drug) | Consulting Fee | Cash or cash equivalent | $600.00 | General |
| Category: Endocrinology | ||||||
| 02/28/2024 | IBSA Pharma Inc. | Tirosint (Drug), Licart | Food and Beverage | Cash or cash equivalent | $16.75 | General |
| Category: Endocrinology | ||||||
| 02/20/2024 | IBSA Pharma Inc. | Tirosint (Drug), Licart | Food and Beverage | Cash or cash equivalent | $11.40 | General |
| Category: Endocrinology | ||||||
| 01/30/2024 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $37.98 | General |
| Category: THERAPY FOR CSID | ||||||
| 01/18/2024 | IBSA Pharma Inc. | Tirosint (Drug), Licart | Food and Beverage | Cash or cash equivalent | $5.65 | General |
| Category: Endocrinology | ||||||
| 01/16/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $26.30 | General |
| Category: Endocrinology | ||||||
| 12/04/2023 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $32.80 | General |
| Category: Endocrinology | ||||||
| 11/14/2023 | QOL Medical, LLC | Sucraid (Drug) | Food and Beverage | Cash or cash equivalent | $42.68 | General |
| Category: THERAPY FOR CSID | ||||||
| 11/14/2023 | IBSA Pharma Inc. | LICART (Drug), TIROSINT, TIROSINT | Food and Beverage | Cash or cash equivalent | $12.64 | General |
| Category: non-opioid analgesic | ||||||
| 09/22/2023 | Acella Pharmaceuticals, LLC | NP Thyroid 60 (Drug) | Food and Beverage | In-kind items and services | $14.12 | General |
| Category: Hyperthyroidism | ||||||
| 09/14/2023 | QOL Medical, LLC | Sucraid (Drug) | Food and Beverage | Cash or cash equivalent | $32.50 | General |
| Category: THERAPY FOR CSID | ||||||
| 07/06/2023 | QOL Medical, LLC | Sucraid (Drug) | Food and Beverage | Cash or cash equivalent | $38.70 | General |
| Category: THERAPY FOR CSID | ||||||
| 06/26/2023 | IBSA Pharma Inc. | LICART (Drug), TIROSINT, TIROSINT | Food and Beverage | Cash or cash equivalent | $6.65 | General |
| Category: non-opioid analgesic | ||||||
| 06/20/2023 | Regeneron Healthcare Solutions, Inc. | EVKEEZA (Biological) | Food and Beverage | In-kind items and services | $25.48 | General |
| Category: CARDIOVASCULAR AND METABOLISM | ||||||
| 06/16/2023 | IBSA Pharma Inc. | LICART (Drug), TIROSINT, TIROSINT | Food and Beverage | Cash or cash equivalent | $6.54 | General |
| Category: non-opioid analgesic | ||||||
| 06/08/2023 | IBSA Pharma Inc. | LICART (Drug), TIROSINT, TIROSINT | Food and Beverage | Cash or cash equivalent | $5.55 | General |
| Category: non-opioid analgesic | ||||||
About Dr. Elizabeth Board, MD
Dr. Elizabeth Board, MD is a General Practice healthcare provider based in Alpharetta, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/24/2007. The National Provider Identifier (NPI) number assigned to this provider is 1740476787.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Elizabeth Board, MD has received a total of $7,506 in payments from pharmaceutical and medical device companies, with $2,502 received in 2024. These payments were reported across 123 transactions from 13 companies. The most common payment nature is "Consulting Fee" ($4,150).
Practice Information
- Specialty General Practice
- Other Specialties Acupuncturist, Specialist
- Location Alpharetta, GA
- Active Since 09/24/2007
- Last Updated 01/15/2014
- Taxonomy Code 208D00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1740476787
Products in Payments
- Tirosint (Drug) $5,281
- XIFAXAN (Drug) $655.31
- Alinia Tablets 500mg 30 count bottle (Drug) $316.73
- SUCRAID (Drug) $263.37
- ALINIA (Drug) $225.64
- Sucraid (Drug) $206.38
- Alinia (Drug) $135.75
- LICART (Drug) $59.37
- Korlym (Drug) $59.10
- SIMPONI (Biological) $41.89
- XIFAXANIBSD (Drug) $39.28
- EVKEEZA (Biological) $25.48
- TRULANCE (Drug) $21.12
- Licart (Drug) $20.14
- NEXLETOL (Drug) $18.55
- LINZESS (Drug) $18.40
- Adthyza (Drug) $17.13
- FibroScan (Device) $14.71
- NP Thyroid 60 (Drug) $14.12
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
General Practice Doctors in Alpharetta
Dr. Imad Sabbagh, D.d.s, D.D.S
General Practice — Payments: $3,494
Dr. Cesar Tapia-Vera, Dds, DDS
General Practice — Payments: $3,365
Dr. Larry Gurley, Dds, DDS
General Practice — Payments: $3,254
Dr. Brett Silverman, Dds, Magd, Llsr, DDS, MAGD, LLSR
General Practice — Payments: $2,752
Dr. Kimberly Green, D.o, D.O
General Practice — Payments: $2,676
Scott Fleming, D.d.s, D.D.S
General Practice — Payments: $2,191